دورية أكاديمية
[Acetylsalicylic acid in primary and secondary prevention of atherosclerotic cardiovascular disease].
| العنوان: | [Acetylsalicylic acid in primary and secondary prevention of atherosclerotic cardiovascular disease]. |
|---|---|
| عنوان ترانسليتريتد: | Primenenie atsetilsalitsilovoi kisloty pri pervichnoi i vtorichnoi profilaktike ateroskleroticheskikh serdechno-sosudistykh zabolevanii. |
| المؤلفون: | Oynotkinova OS; Research Institute of Health Organization and Medical Management, Moscow, Russia.; Central State Medical Academy of the Office of the President of the Russian Federation, Moscow, Russia., Matskeplishvili ST; Lomonosov Moscow State University, Moscow, Russia., Maslennikova OM; Central State Medical Academy of the Office of the President of the Russian Federation, Moscow, Russia., Pavlov AI; National Medical Research Center for High Medical Technologies - Vishnevsky Central Military Clinical Hospital, Krasnogorsk, Russia., Poberezhskaya AG; Sochi Central Clinical Hospital, Sochi, Russia. |
| المصدر: | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (5), pp. 58-64. |
| نوع المنشور: | English Abstract; Journal Article |
| اللغة: | Russian |
| بيانات الدورية: | Publisher: Media Sfera Country of Publication: Russia (Federation) NLM ID: 9712194 Publication Model: Print Cited Medium: Print ISSN: 1997-7298 (Print) Linking ISSN: 19977298 NLM ISO Abbreviation: Zh Nevrol Psikhiatr Im S S Korsakova Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <1995->: Moskva : Media Sfera Original Publication: Moskva : "Meditsina", |
| مواضيع طبية MeSH: | Cardiovascular Diseases*/prevention & control , Atherosclerosis*/prevention & control, Male ; Humans ; Adult ; Middle Aged ; Aged ; Secondary Prevention ; Aspirin/therapeutic use ; Gastrointestinal Tract |
| مستخلص: | The article is devoted to an urgent problem - primary and secondary prevention of atherosclerotic cardiovascular diseases. Modern approaches to management tactics depending on age and the appointment of antiplatelet therapy with acetylsalicylic acid in low doses from 75 to 150 mg/day are presented. At the same time, the relatively high effectiveness of the use of ASA for primary prevention in men 40-69 years old without an increased risk of bleeding from the gastrointestinal tract is shown. Low doses of ASA provide little benefit in reducing the risk of CVD in people 40 years and older, when there is no history of CVD, but at the same time they are at increased risk of CVD. |
| فهرسة مساهمة: | Keywords: atherosclerotic cardiovascular diseases; intestinal soluble acetylsalicylic acid; ischemic stroke; low doses; primary; secondary prevention Local Abstract: [Publisher, Russian] Статья посвящена проблеме первичной и вторичной профилактики атеросклеротических сердечно-сосудистых заболеваний (ССЗ). Представлены современные подходы к ведению пациентов разного возраста с назначением антитромбоцитарной терапии ацетилсалициловой кислотой (АСК) в дозах от 75 до 150 мг/сут. Показана эффективность применения АСК для первичной профилактики ССЗ у некоторых групп мужчин 40—69 лет без повышенного риска кровотечений из желудочно-кишечного тракта. Низкие дозы АСК дают небольшую пользу в снижении риска ССЗ у пациентов 40 лет и старше без ССЗ, но с повышенным риском их развития. |
| المشرفين على المادة: | R16CO5Y76E (Aspirin) |
| تواريخ الأحداث: | Date Created: 20230614 Date Completed: 20230616 Latest Revision: 20230616 |
| رمز التحديث: | 20240829 |
| DOI: | 10.17116/jnevro202312305158 |
| PMID: | 37315243 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1997-7298 |
|---|---|
| DOI: | 10.17116/jnevro202312305158 |